highly significantP = 0.002
The highly significant benefit of empagliflozin ( P = 0.002) in preventing hospitalization for heart failure raises hope for its use in this clinical situation [ 1 ].
The highly significant benefit of empagliflozin ( P = 0.002) in preventing hospitalization for heart failure raises hope for its use in this clinical situation [ 1 ].
However, the difference in rates of non-fatal MI and non-fatal stroke did not reach statistical significance.